Company / Depreciation & Amortization
Axsome Therapeutics, Inc. Depreciation & Amortization History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$76.0K
FY2021
5-year range
$76.0K / $76.0K
FY2017-FY2021
Trend
+218.5%
vs FY2020
Sector context
#162 of 168
Health Care
What the data says
Depreciation & Amortization changed +218% YoY in FY2021, a notable deviation from the 5-year average annual change of +56%.
Based on SEC 10-K filings.
$76,000 in FY2021 with a 5-year CAGR of +30.0%.
Increased from $37,330 to $76,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +30.0%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 168This company $76.0K Sector average $212.9M
▼
-100.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.0%, indicating consistent growth.
- In FY2021, depreciation & amortization increased 218.5% year-over-year.
- Ranks #162 out of 168 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $76.0K | +218.5% |
| FY2020 | $23.9K | -36.1% |
| FY2019 | $37.3K | -23.7% |
| FY2018 | $48.9K | +15.0% |
| FY2017 | $42.6K | +107.8% |
| FY2016 | $20.5K | +478.3% |
As of FY2021 · SEC 10-K · Updated Feb 28, 2026